Skip to main content
OTCMKTS:BPSR

Organicell Regenerative Medicine Competitors

$0.22
-0.02 (-8.30 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.22
$0.28
50-Day Range
$0.05
$0.60
52-Week Range
$0.04
$0.63
Volume4.36 million shs
Average Volume4.80 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Organicell Regenerative Medicine (OTCMKTS:BPSR) Vs. DDXS, TNGN, ATTBF, ADTX, AGNPF, and LBTSF

Should you be buying BPSR stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Organicell Regenerative Medicine, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), and Almirall (LBTSF).

(DDXS) (OTCMKTS:DDXS) and Organicell Regenerative Medicine (OTCMKTS:BPSR) are both health technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, dividends and risk.

Profitability

This table compares (DDXS) and Organicell Regenerative Medicine's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
Organicell Regenerative MedicineN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for (DDXS) and Organicell Regenerative Medicine, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Organicell Regenerative Medicine0000N/A

Earnings and Valuation

This table compares (DDXS) and Organicell Regenerative Medicine's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Organicell Regenerative MedicineN/AN/AN/AN/AN/A

Organicell Regenerative Medicine (OTCMKTS:BPSR) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Organicell Regenerative Medicine and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Organicell Regenerative MedicineN/AN/AN/A
(TNGN)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Organicell Regenerative Medicine and (TNGN), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Organicell Regenerative Medicine0000N/A
(TNGN)0000N/A

Earnings & Valuation

This table compares Organicell Regenerative Medicine and (TNGN)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organicell Regenerative MedicineN/AN/AN/AN/AN/A
(TNGN)N/AN/AN/AN/AN/A

Organicell Regenerative Medicine (OTCMKTS:BPSR) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Organicell Regenerative Medicine and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Organicell Regenerative MedicineN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Organicell Regenerative Medicine and Abattis Bioceuticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Organicell Regenerative Medicine0000N/A
Abattis Bioceuticals0000N/A

Earnings & Valuation

This table compares Organicell Regenerative Medicine and Abattis Bioceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organicell Regenerative MedicineN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Organicell Regenerative Medicine (OTCMKTS:BPSR) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Organicell Regenerative Medicine and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Organicell Regenerative MedicineN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Organicell Regenerative Medicine and ADiTx Therapeutics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Organicell Regenerative Medicine0000N/A
ADiTx Therapeutics00103.00

Earnings & Valuation

This table compares Organicell Regenerative Medicine and ADiTx Therapeutics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organicell Regenerative MedicineN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Summary

ADiTx Therapeutics beats Organicell Regenerative Medicine on 1 of the 1 factors compared between the two stocks.

Organicell Regenerative Medicine (OTCMKTS:BPSR) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Organicell Regenerative Medicine and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Organicell Regenerative MedicineN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Organicell Regenerative Medicine and Algernon Pharmaceuticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Organicell Regenerative Medicine0000N/A
Algernon Pharmaceuticals0000N/A

Earnings & Valuation

This table compares Organicell Regenerative Medicine and Algernon Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organicell Regenerative MedicineN/AN/AN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/AN/AN/A

Organicell Regenerative Medicine (OTCMKTS:BPSR) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Organicell Regenerative Medicine and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Organicell Regenerative MedicineN/AN/AN/A
AlmirallN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Organicell Regenerative Medicine and Almirall, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Organicell Regenerative Medicine0000N/A
Almirall01102.50

Earnings & Valuation

This table compares Organicell Regenerative Medicine and Almirall's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organicell Regenerative MedicineN/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Summary

Almirall beats Organicell Regenerative Medicine on 1 of the 1 factors compared between the two stocks.


Organicell Regenerative Medicine Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00-0.0%$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Down
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.01-0.0%$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.30-1.3%$0.00N/A0.00Earnings Announcement
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13-0.0%$0.00N/A0.00News Coverage
Almirall logo
LBTSF
Almirall
0.5$15.15-1.5%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.06-0.0%$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01-0.0%$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.00-92,400.0%$0.00N/A0.00Gap Down
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.67-10.4%$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52-0.0%$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.19-0.0%$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23-56.1%$0.00N/A0.00Gap Up
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.05-0.0%$0.00N/A0.00
CGYG
China Longyi Group International
0.4$0.00-0.0%$0.00N/A0.00
Claritas Pharmaceuticals logo
KALTF
Claritas Pharmaceuticals
0.6$0.03-0.0%$0.00N/A0.00Gap Down
CLVLY
Clinuvel Pharmaceuticals
1.0$22.65-4.9%$0.00N/A0.00Gap Up
CELZ
Creative Medical Technology
0.5$0.03-0.0%$0.00N/A0.00News Coverage
Gap Down
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00-33.3%$0.00N/A0.00News Coverage
Gap Up
EMMBF
Emblem
0.6$1.40-1.4%$0.00N/A0.00
ENZC
Enzolytics
0.0$0.12-16.1%$0.00N/A0.00Gap Down
GB Sciences logo
GBLX
GB Sciences
0.5$0.05-20.0%$0.00N/A0.00News Coverage
Gap Down
Genfit logo
GNFTF
Genfit
0.5$4.17-0.0%$0.00N/A0.00News Coverage
GMXAY
GENMAB A/S/S
0.5$37.08-1.0%$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$66.00-0.0%$0.00N/A0.00
HALB
Halberd
0.0$0.03-0.0%$0.00N/A0.00News Coverage
Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.63-0.4%$0.00N/A0.00News Coverage
Idorsia logo
IDRSF
Idorsia
0.5$25.00-4.2%$0.00N/A0.00Gap Down
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.19-0.0%$0.00N/A0.00
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00-0.0%$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.34-0.0%$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.27-0.9%$0.00N/A0.00News Coverage
Gap Down
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$3.23-7.4%$0.00N/A0.00Gap Down
Molecular Partners logo
MLLCF
Molecular Partners
0.5$22.48-0.4%$0.00N/A0.00
MorphoSys logo
MPSYF
MorphoSys
0.0$93.05-0.0%$0.00N/A0.00
NRNVF
Nordic Nanovector ASA
0.0$1.64-0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$74.15-5.7%$0.00N/A0.00Gap Up
Oxurion logo
TBGNF
Oxurion
0.5$2.94-0.0%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.0$3.99-0.0%$0.00N/A0.00
PTEO
Proteo
0.5$0.09-0.0%$0.00N/A0.00
PROT
Proteonomix
0.5$0.02-0.0%$0.00N/A0.00
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.20-6.6%$0.00N/A0.00Gap Up
PureTech Health logo
PTCHF
PureTech Health
0.0$5.24-0.7%$0.00N/A0.00
RCPHF
Recipharm AB (publ)
1.0$16.05-0.0%$0.00N/A0.00High Trading Volume
Regen BioPharma logo
RGBP
Regen BioPharma
0.0$0.02-2.5%$0.00N/A0.00News Coverage
Relief Therapeutics logo
RLFTF
Relief Therapeutics
0.5$0.22-4.5%$0.00N/A0.00News Coverage
BSSP
Reve Technologies
0.0$0.00-14.3%$0.00N/A0.00Gap Up
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.